Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Judo Bio Inc Developer of oligonucleotide medicines delivered to the kidney. |
United States | 7 Oct 2024 | Series A Initial investment. Round participant. Active |
|
|
Somatix |
N/A Active |